000			02103 a2200625 4500
005			20250518044013.0
264		0	_c20200305
008			202003s 0 0 eng d
022			_a1872-8332
024	7		_a10.1016/j.lungcan.2019.05.011 _2doi
040			_aNLM _beng _cNLM
100	1		_aAwad, Mark M
245	0	0	_aImpact of MET inhibitors on survival among patients with non-small cell lung cancer harboring MET exon 14 mutations: a retrospective analysis. _h[electronic resource]
260			_bLung cancer (Amsterdam, Netherlands) _c07 2019
300			_a96-102 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aCrizotinib _xtherapeutic use
650	0	4	_aExons _xgenetics
650	0	4	_aFemale
650	0	4	_aHigh-Throughput Nucleotide Sequencing
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMutation _xgenetics
650	0	4	_aProtein Kinase Inhibitors _xtherapeutic use
650	0	4	_aProto-Oncogene Proteins c-met _xantagonists & inhibitors
650	0	4	_aRetrospective Studies
650	0	4	_aSurvival Analysis
700	1		_aLeonardi, Giulia C
700	1		_aKravets, Sasha
700	1		_aDahlberg, Suzanne E
700	1		_aDrilon, Alexander
700	1		_aNoonan, Sinead A
700	1		_aCamidge, D Ross
700	1		_aOu, Sai-Hong I
700	1		_aCosta, Daniel B
700	1		_aGadgeel, Shirish M
700	1		_aSteuer, Conor E
700	1		_aForde, Patrick M
700	1		_aZhu, Viola W
700	1		_aFukuda, Yoko
700	1		_aClark, Jeffrey W
700	1		_aJänne, Pasi A
700	1		_aMok, Tony
700	1		_aSholl, Lynette M
700	1		_aHeist, Rebecca S
773	0		_tLung cancer (Amsterdam, Netherlands) _gvol. 133 _gp. 96-102
856	4	0	_uhttps://doi.org/10.1016/j.lungcan.2019.05.011 _zAvailable from publisher's website
999			_c29800075 _d29800075